1 |
Burkauskas J, Slabadiene M, Podlipskyte A, Steibliene V. Factors associated with worsened clinical symptoms of psoriasis and disease-related quality of life during the COVID-19 lockdown: A cross-sectional study. Front Med (Lausanne) 2022;9:1027853. [PMID: 36703886 DOI: 10.3389/fmed.2022.1027853] [Reference Citation Analysis]
|
2 |
Lynde C, Riedl E, Maul J, Torres T, Pinter A, Fabbrocini G, Daniele F, Brnabic A, Reed C, Wilhelm S, Holzkämper T, Schuster C, Puig L. Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting. Adv Ther 2022. [DOI: 10.1007/s12325-022-02379-9] [Reference Citation Analysis]
|
3 |
Balato A, Zink A, Babino G, Buononato D, Kiani C, Eyerich K, Ziehfreund S, Scala E. The Impact of Psoriasis and Atopic Dermatitis on Quality of Life: A Literature Research on Biomarkers. Life (Basel) 2022;12. [PMID: 36556392 DOI: 10.3390/life12122026] [Reference Citation Analysis]
|
4 |
Nojiri Y, Nakamura M, Magara T, Yamamoto A, Ikumi K, Nakamura R, Nishida E, Haarmann-stemmann T, Morita A. Aldo-keto reductase 1C3, which contributes to skin barrier function, is downregulated by single nucleotide polymorphisms predominantly in females with early-onset psoriasis.. [DOI: 10.21203/rs.3.rs-2261002/v1] [Reference Citation Analysis]
|
5 |
Adachi A, Honda T. Regulatory Roles of Estrogens in Psoriasis. J Clin Med 2022;11:4890. [PMID: 36013129 DOI: 10.3390/jcm11164890] [Reference Citation Analysis]
|